Patient, Physician, and Caregiver Preferences for Lung Cancer Treatment: A Systematic Review of Discrete Choice Experiments.

Sida Wang, Yun Liu, Mengyu Yang, Linning Wang, Jie Yu, Xiaoxi Xie, Feng Chang, Yun Lu

Abstract readReview

In one paragraph

Review in Healthcare (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it

0cells of the map it votes in

1citing papers in PubMed, 1 pooled it

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

Preferences for AI-Enabled Health Care Technologies: Systematic Review of Discrete Choice Experiments and Reporting Quality Assessment Using the DIRECT Checklist.Journal of medical Internet research · 2026
Pooled it

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Sida WangSchool of International Pharmaceutical Business, China Pharmaceutical University, No. 639 Longmian Avenue, Nanjing 211198, China.

Yun LiuSchool of International Pharmaceutical Business, China Pharmaceutical University, No. 639 Longmian Avenue, Nanjing 211198, China.ORCID 0009-0000-5774-4893

Mengyu YangSchool of International Pharmaceutical Business, China Pharmaceutical University, No. 639 Longmian Avenue, Nanjing 211198, China.

Linning WangSchool of International Pharmaceutical Business, China Pharmaceutical University, No. 639 Longmian Avenue, Nanjing 211198, China.

Jie YuSchool of International Pharmaceutical Business, China Pharmaceutical University, No. 639 Longmian Avenue, Nanjing 211198, China.

Xiaoxi XieSchool of International Pharmaceutical Business, China Pharmaceutical University, No. 639 Longmian Avenue, Nanjing 211198, China.

Feng ChangSchool of International Pharmaceutical Business, China Pharmaceutical University, No. 639 Longmian Avenue, Nanjing 211198, China.

Yun LuSchool of International Pharmaceutical Business, China Pharmaceutical University, No. 639 Longmian Avenue, Nanjing 211198, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

different stakeholdersdiscrete choice experimentslung cancerpreferencessystematic review

Identifiers

PMID41827538

DOI10.3390/healthcare14050584

PMCPMC12984755

What Socratic holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.